IP Verse

Sanofi Biotechnology competitive analysis

Loading summary...

Latest patents of Sanofi Biotechnology opposed by its competitors

Explore Sanofi Biotechnology's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3506931
Jul 31, 2024Methods For Preventing Or Treating Allergy By Administering An Il-4R Antagonist4
EP3889181
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist7
EP3110848
Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R Antagonist5
EP3515465
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R Inhibitor7
EP3973987
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
EP4011915
Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist6
EP3703818
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist7
EP3470432
Oct 6, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist4
EP3107575
Sep 1, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist3
EP2892927
May 9, 2018Methods For Treating Atopic Dermatitis By Administering An Il-4R Antagonist1

Latest publications and patents of Sanofi Biotechnology New

Explore the latest publications and patents granted to Sanofi Biotechnology, showcasing their recent innovations and technological advancements.

Last updated on: Oct 20, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Sanofi Biotechnology

EP3506931
Jul 31, 2024Methods For Preventing Or Treating Allergy By Administering An Il-4R AntagonistGranted And Under Opposition
EP3889181
Apr 24, 2024Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistGranted And Under Opposition
EP3110848
Feb 14, 2024Methods For Treating Skin Infection By Administering An Il-4R AntagonistGranted And Under Opposition
EP3515465
Feb 7, 2024Methods For Treating Severe Atopic Dermatitis By Administering An Il-4R InhibitorGranted And Under Opposition
EP3973987
Jan 10, 2024Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistGranted And Under Opposition
EP4011915
Nov 15, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistGranted And Under Opposition
EP3703818
Nov 1, 2023Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistGranted And Under Opposition
EP3470432
Oct 6, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistRevoked
EP3107575
Sep 1, 2021Methods For Treating Or Preventing Asthma By Administering An Il-4R AntagonistGranted And Under Opposition
EP2892927
May 9, 2018Methods For Treating Atopic Dermatitis By Administering An Il-4R AntagonistRevoked

Latest PTAB cases involving Sanofi Biotechnology

Discover the latest PTAB cases involving Sanofi Biotechnology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Sanofi Biotechnology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SANOFI BIOTECHNOLOGY - 51 - -
BOULT WADE TENNANT52 - - -
HAMPTON KNOWLES24 - - -
SECERNA11 - - -